443 related articles for article (PubMed ID: 35236351)
1. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Zhang Q; Chen S; Ke Y; Li Q; Shen C; Ruan Y; Wu K; Hu J; Liu S
Front Endocrinol (Lausanne); 2023; 14():1073498. PubMed ID: 37139340
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
4. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
[TBL] [Abstract][Full Text] [Related]
6. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
7. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
8. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA
J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724
[TBL] [Abstract][Full Text] [Related]
9. Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Rastkar M; Nikniaz L; Farhangi MA; Nikniaz Z
J Diabetes Metab Disord; 2023 Jun; 22(1):83-95. PubMed ID: 37255767
[TBL] [Abstract][Full Text] [Related]
10. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
Makri ES; Evripidou K; Polyzos SA
J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease.
Liu S; Xiao J; Zhao Z; Wang M; Wang Y; Xin Y
J Clin Transl Hepatol; 2021 Feb; 9(1):3-14. PubMed ID: 33604250
[TBL] [Abstract][Full Text] [Related]
12. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M;
Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100
[TBL] [Abstract][Full Text] [Related]
13. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
[TBL] [Abstract][Full Text] [Related]
14. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Han D; Chen J; Liu S; Zhang Z; Zhao Z; Jin W; Xin Y
J Clin Transl Hepatol; 2021 Aug; 9(4):484-493. PubMed ID: 34447677
[TBL] [Abstract][Full Text] [Related]
15. Serum chemerin and vaspin in non-alcoholic fatty liver disease.
Kukla M; Zwirska-Korczala K; Hartleb M; Waluga M; Chwist A; Kajor M; Ciupinska-Kajor M; Berdowska A; Wozniak-Grygiel E; Buldak R
Scand J Gastroenterol; 2010; 45(2):235-42. PubMed ID: 20095887
[TBL] [Abstract][Full Text] [Related]
16. Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis.
Gao Y; Xin C; Fan H; Sun X; Wang H
Front Endocrinol (Lausanne); 2022; 13():1076951. PubMed ID: 36714603
[TBL] [Abstract][Full Text] [Related]
17. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.
Dai YN; Xu CF; Pan HY; Huang HJ; Chen MJ; Li YM; Yu CH
World J Clin Cases; 2022 May; 10(13):4097-4109. PubMed ID: 35665109
[TBL] [Abstract][Full Text] [Related]
18. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.
Sun J; Ren J; Zuo C; Deng D; Pan F; Chen R; Zhu J; Chen C; Ye S
Lipids Health Dis; 2020 Feb; 19(1):26. PubMed ID: 32087711
[TBL] [Abstract][Full Text] [Related]
19. Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.
Kajor M; Kukla M; Waluga M; Liszka Ł; Dyaczyński M; Kowalski G; Żądło D; Berdowska A; Chapuła M; Kostrząb-Zdebel A; Bułdak RJ; Sawczyn T; Hartleb M
Pol J Pathol; 2017; 68(2):117-127. PubMed ID: 29025245
[TBL] [Abstract][Full Text] [Related]
20. The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis.
Agustanti N; Soetedjo NNM; Damara FA; Iryaningrum MR; Permana H; Bestari MB; Supriyadi R
Diabetes Metab Syndr; 2023 May; 17(5):102780. PubMed ID: 37201293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]